{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:42:00Z","timestamp":1784266920359,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:00:00Z","timestamp":1539561600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00259-018-4183-0","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T18:27:55Z","timestamp":1539628075000},"page":"376-384","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Myocardial MIBG scintigraphy in genetic Parkinson\u2019s disease as a model for Lewy body disorders"],"prefix":"10.1007","volume":"46","author":[{"given":"I\u00f1igo","family":"Gabilondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Llorens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinidad","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas P\u00e9rez","family":"Concha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Acera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Tijero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ane","family":"Murueta-Goyena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"del Pino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"G\u00f3mez-Esteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,15]]},"reference":[{"key":"4183_CR1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/B978-0-444-53491-0.00029-8","volume":"117","author":"DS Goldstein","year":"2013","unstructured":"Goldstein DS. Sympathetic neuroimaging. Handb Clin Neurol. 2013;117:365\u201370. \n                    https:\/\/doi.org\/10.1016\/B978-0-444-53491-0.00029-8\n                    \n                  .","journal-title":"Handb Clin Neurol"},{"key":"4183_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1136\/jnnp.67.2.189","volume":"67","author":"S Orimo","year":"1999","unstructured":"Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 1999;67:189\u201394.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4183_CR3","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1212\/01.wnl.0000249313.25627.2e","volume":"67","author":"T Miyamoto","year":"2006","unstructured":"Miyamoto T, Miyamoto M, Inoue Y, Usui Y, Suzuki K, Hirata K. Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder. Neurology. 2006;67:2236\u20138. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000249313.25627.2e\n                    \n                  .","journal-title":"Neurology"},{"key":"4183_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.parkreldis.2011.08.018","volume":"18","author":"K Berganzo","year":"2012","unstructured":"Berganzo K, Tijero B, Somme JH, Llorens V, Sanchez-Manso JC, Low D, et al. SCOPA-AUT scale in different parkinsonisms and its correlation with (123)I-MIBG cardiac scintigraphy. Parkinsonism Relat Disord. 2012;18:45\u20138. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2011.08.018\n                    \n                  .","journal-title":"Parkinsonism Relat Disord"},{"key":"4183_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/BF02984560","volume":"18","author":"J Taki","year":"2004","unstructured":"Taki J, Yoshita M, Yamada M, Tonami N. Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson\u2019s disease and related disorders: it can be a specific marker for Lewy body disease. Ann Nucl Med. 2004;18:453\u201361.","journal-title":"Ann Nucl Med"},{"key":"4183_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jns.2005.08.011","volume":"240","author":"M Suzuki","year":"2006","unstructured":"Suzuki M, Kurita A, Hashimoto M, Fukumitsu N, Abo M, Ito Y, et al. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease. J Neurol Sci. 2006;240:15\u20139. \n                    https:\/\/doi.org\/10.1016\/j.jns.2005.08.011\n                    \n                  .","journal-title":"J Neurol Sci"},{"key":"4183_CR7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.parkreldis.2009.12.010","volume":"16","author":"K Kashihara","year":"2010","unstructured":"Kashihara K, Imamura T, Shinya T. Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson's disease. Parkinsonism Relat Disord. 2010;16:252\u20135. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2009.12.010\n                    \n                  .","journal-title":"Parkinsonism Relat Disord"},{"key":"4183_CR8","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1212\/01.wnl.0000435553.67953.81","volume":"81","author":"H Oda","year":"2013","unstructured":"Oda H, Ishii K, Terashima A, Shimada K, Yamane Y, Kawasaki R, et al. Myocardial scintigraphy may predict the conversion to probable dementia with Lewy bodies. Neurology. 2013;81:1741\u20135. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000435553.67953.81\n                    \n                  .","journal-title":"Neurology"},{"key":"4183_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol. 2004;55:164\u201373. \n                    https:\/\/doi.org\/10.1002\/ana.10795\n                    \n                  .","journal-title":"Ann Neurol"},{"key":"4183_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.parkreldis.2012.08.001","volume":"19","author":"B Tijero","year":"2013","unstructured":"Tijero B, Gomez-Esteban JC, Lezcano E, Fernandez-Gonzalez C, Somme J, Llorens V, et al. Cardiac sympathetic denervation in symptomatic and asymptomatic carriers of the E46K mutation in the alpha synuclein gene. Parkinsonism Relat Disord. 2013;19:95\u2013100. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2012.08.001\n                    \n                  .","journal-title":"Parkinsonism Relat Disord"},{"key":"4183_CR11","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1093\/brain\/awh081","volume":"127","author":"A Singleton","year":"2004","unstructured":"Singleton A, Gwinn-Hardy K, Sharabi Y, Li ST, Holmes C, Dendi R, et al. Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication. Brain. 2004;127:768\u201372. \n                    https:\/\/doi.org\/10.1093\/brain\/awh081\n                    \n                  .","journal-title":"Brain"},{"key":"4183_CR12","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.parkreldis.2015.04.012","volume":"21","author":"B Tijero","year":"2015","unstructured":"Tijero B, Gabilondo I, Lezcano E, Teran-Villagra N, Llorens V, Ruiz-Martinez J, et al. Autonomic involvement in parkinsonian carriers of PARK2 gene mutations. Parkinsonism Relat Disord. 2015;21:717\u201322. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2015.04.012\n                    \n                  .","journal-title":"Parkinsonism Relat Disord"},{"key":"4183_CR13","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1007\/s00415-010-5896-6","volume":"258","author":"F Valldeoriola","year":"2011","unstructured":"Valldeoriola F, Gaig C, Muxi A, Navales I, Paredes P, Lomena F, et al. 123I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations. J Neurol. 2011;258:1126\u201332. \n                    https:\/\/doi.org\/10.1007\/s00415-010-5896-6\n                    \n                  .","journal-title":"J Neurol"},{"key":"4183_CR14","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1002\/mds.26712","volume":"31","author":"J Nonnekes","year":"2016","unstructured":"Nonnekes J, Timmer MH, de Vries NM, Rascol O, Helmich RC, Bloem BR. Unmasking levodopa resistance in Parkinson\u2019s disease. Mov Disord. 2016;31:1602\u20139. \n                    https:\/\/doi.org\/10.1002\/mds.26712\n                    \n                  .","journal-title":"Mov Disord"},{"key":"4183_CR15","first-page":"1326","volume":"17","author":"A Stefanelli","year":"2013","unstructured":"Stefanelli A, Treglia G, Bruno I, Rufini V, Giordano A. Pharmacological interference with 123I-metaiodobenzylguanidine: a limitation to developing cardiac innervation imaging in clinical practice? Eur Rev Med Pharmacol Sci. 2013;17:1326\u201333.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4183_CR16","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1007\/s00259-010-1491-4","volume":"37","author":"A Flotats","year":"2010","unstructured":"Flotats A, Carrio I, Agostini D, Le Guludec D, Marcassa C, Schafers M, et al. Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging. 2010;37:1802\u201312. \n                    https:\/\/doi.org\/10.1007\/s00259-010-1491-4\n                    \n                  .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4183_CR17","doi-asserted-by":"publisher","unstructured":"Verschure DO, Poel E, Nakajima K, Okuda K, van Eck-Smit BL, Somsen GA, et al. A European myocardial (123)I-mIBG cross-calibration phantom study. J Nucl Cardiol. 2018;25:1191\u20137. \n                    https:\/\/doi.org\/10.1007\/s12350-017-0782-6\n                    \n                  .","DOI":"10.1007\/s12350-017-0782-6"},{"key":"4183_CR18","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S1071-3581(03)00652-4","volume":"10","author":"Y Inoue","year":"2003","unstructured":"Inoue Y, Suzuki A, Shirouzu I, Machida T, Yoshizawa Y, Akita F, et al. Effect of collimator choice on quantitative assessment of cardiac iodine 123 MIBG uptake. J Nucl Cardiol. 2003;10:623\u201332.","journal-title":"J Nucl Cardiol"},{"key":"4183_CR19","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/aje\/kwj063","volume":"163","author":"NJ Perkins","year":"2006","unstructured":"Perkins NJ, Schisterman EF. The inconsistency of \"optimal\" cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol. 2006;163:670\u20135. \n                    https:\/\/doi.org\/10.1093\/aje\/kwj063\n                    \n                  .","journal-title":"Am J Epidemiol"},{"key":"4183_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1145\/1656274.1656278","volume":"11","author":"M Hall","year":"2009","unstructured":"Hall M, Frank E, Holmes G, Pfahringer B, Reutemann P, Witten IH. The WEKA data mining software: an update. J SIGKDD Explor Newsl. 2009;11:10\u20138. \n                    https:\/\/doi.org\/10.1145\/1656274.1656278\n                    \n                  .","journal-title":"J SIGKDD Explor Newsl"},{"key":"4183_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/01.ede.0000147512.81966.ba","volume":"16","author":"EF Schisterman","year":"2005","unstructured":"Schisterman EF, Perkins NJ, Liu A, Bondell H. Optimal cut-point and its corresponding Youden index to discriminate individuals using pooled blood samples. Epidemiology. 2005;16:73\u201381.","journal-title":"Epidemiology"},{"key":"4183_CR22","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.parkreldis.2013.05.008","volume":"19","author":"B Tijero","year":"2013","unstructured":"Tijero B, Gomez Esteban JC, Somme J, Llorens V, Lezcano E, Martinez A, et al. Autonomic dysfunction in parkinsonian LRRK2 mutation carriers. Parkinsonism Relat Disord. 2013;19:906\u20139. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2013.05.008\n                    \n                  .","journal-title":"Parkinsonism Relat Disord"},{"key":"4183_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12883-015-0338-9","volume":"15","author":"G Lamotte","year":"2015","unstructured":"Lamotte G, Morello R, Lebasnier A, Agostini D, Defer GL. Accuracy and cutoff values of delayed heart to mediastinum ratio with (123)I-metaiodobenzylguanidine cardiac scintigraphy for Lewy body disease diagnoses. BMC Neurol. 2015;15:83. \n                    https:\/\/doi.org\/10.1186\/s12883-015-0338-9\n                    \n                  .","journal-title":"BMC Neurol"},{"key":"4183_CR24","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/sleep\/31.5.717","volume":"31","author":"T Miyamoto","year":"2008","unstructured":"Miyamoto T, Miyamoto M, Suzuki K, Nishibayashi M, Iwanami M, Hirata K. 123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder. Sleep. 2008;31:717\u201323.","journal-title":"Sleep"},{"key":"4183_CR25","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1212\/WNL.53.5.1020","volume":"53","author":"S Braune","year":"1999","unstructured":"Braune S, Reinhardt M, Schnitzer R, Riedel A, Lucking CH. Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy. Neurology. 1999;53:1020\u20135.","journal-title":"Neurology"},{"key":"4183_CR26","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/mds.25844","volume":"29","author":"D Berg","year":"2014","unstructured":"Berg D, Postuma RB, Bloem B, Chan P, Dubois B, Gasser T, et al. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Mov Disord. 2014;29:454\u201362. \n                    https:\/\/doi.org\/10.1002\/mds.25844\n                    \n                  .","journal-title":"Mov Disord"},{"key":"4183_CR27","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1002\/mds.23338","volume":"25","author":"H Nagayama","year":"2010","unstructured":"Nagayama H, Ueda M, Yamazaki M, Nishiyama Y, Hamamoto M, Katayama Y. Abnormal cardiac [(123)I]-meta-iodobenzylguanidine uptake in multiple system atrophy. Mov Disord. 2010;25:1744\u20137. \n                    https:\/\/doi.org\/10.1002\/mds.23338\n                    \n                  .","journal-title":"Mov Disord"},{"key":"4183_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00401-005-1013-9","volume":"110","author":"M Sone","year":"2005","unstructured":"Sone M, Yoshida M, Hashizume Y, Hishikawa N, Sobue G. \u03b1-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy. Acta Neuropathol. 2005;110:19\u201326. \n                    https:\/\/doi.org\/10.1007\/s00401-005-1013-9\n                    \n                  .","journal-title":"Acta Neuropathol"},{"key":"4183_CR29","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00401-006-0160-y","volume":"113","author":"S Orimo","year":"2007","unstructured":"Orimo S, Kanazawa T, Nakamura A, Uchihara T, Mori F, Kakita A, et al. Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy. Acta Neuropathol. 2007;113:81\u20136. \n                    https:\/\/doi.org\/10.1007\/s00401-006-0160-y\n                    \n                  .","journal-title":"Acta Neuropathol"},{"key":"4183_CR30","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/mds.23659","volume":"26","author":"AE King","year":"2011","unstructured":"King AE, Mintz J, Royall DR. Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders. Mov Disord. 2011;26:1218\u201324. \n                    https:\/\/doi.org\/10.1002\/mds.23659\n                    \n                  .","journal-title":"Mov Disord"},{"key":"4183_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.nuclcard.2005.11.009","volume":"13","author":"S Nagamachi","year":"2006","unstructured":"Nagamachi S, Fujita S, Nishii R, Futami S, Tamura S, Mizuta M, et al. Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non-insulin-dependent diabetes mellitus. J Nucl Cardiol. 2006;13:34\u201342. \n                    https:\/\/doi.org\/10.1016\/j.nuclcard.2005.11.009\n                    \n                  .","journal-title":"J Nucl Cardiol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-018-4183-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-4183-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-4183-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T23:05:55Z","timestamp":1571094355000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-018-4183-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,15]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["4183"],"URL":"https:\/\/doi.org\/10.1007\/s00259-018-4183-0","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,15]]},"assertion":[{"value":"5 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}